Currently we test and support the following browsers:
Brenda Schulman, PhD, of Structural Biology and Genetics and Tumor Cell Biology at St. Jude Children's Research Hospital, has been selected to be a Howard Hughes Medical Institute (HHMI) investigator. She joins Charles Sherr, MD, PhD, Genetics and Tumor Cell Biology co-chair, and James Ihle, PhD, Biochemistry chair, who are also HHMI investigators.
“The HHMI award is a wonderful honor,” Schulman said. “It will encourage me to pursue adventurous problems and will allow me more time to work with the members of the lab.”
Schulman was one of 43 scientists from around the country to be selected through a nationwide competition that began in 2004. The institute asked about 200 universities, medical schools and institutes to nominate candidates who demonstrated exceptional promise within four to 10 years of their becoming independent scientists. More than 300 people were nominated.
“We are committed to providing these scientists—and the nearly 300 scientists who are already part of HHMI—with the freedom and flexibility they need in order to make lasting contributions to mankind,” said Thomas Cech, HHMI’s president. “We want and expect them to be daring.”
Schulman works on the mechanism of protein modification by the family of ubiquitin-related proteins.
She has received a Pew Scholar for Biomedical Sciences and earned a Beckman Young Investigator Award.
To read more about Schulman and how she was inspired by science in high school, and to learn more about the HHMI award, visit www.hhmi.org/news/schulman.html.